A.W.S. Ritchie
Impact in
- Pulmonary and Respiratory Medicine top 0.2%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism
Papers in
-
- Prostate Cancer Treatment and Research 29
- Prostate Cancer Diagnosis and Treatment 18
- Renal cell carcinoma treatment 15
- Kidney Stones and Urolithiasis Treatments 7
-
- Cancer Genomics and Diagnostics 7
- Co-authors
- K. James (12 shared papers)G. D. CHISHOLM (17 shared papers)G. D. Chisholm (2 shared papers)H. Spedding Micklem (4 shared papers)Nicholas David James (15 shared papers)Matthew Robert Sydes (15 shared papers)Noel William Clarke (15 shared papers)Mahesh Parmar (12 shared papers)
- Journals
- Annals of Oncology (8 papers)The Journal of Urology (7 papers)European Urology (3 papers)British Journal of Urology (3 papers)The Lancet (3 papers)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
A.W.S. Ritchie
93 papers receiving 6.9k citations
A.W.S. Ritchie's Hit Papers
Peers
Comparison fields: 5 of 123
- Pulmonary and Respiratory Medicine 4.9k
- Cancer Research 1.0k
- Radiology, Nuclear Medicine and Imaging 925
- Oncology 912
- Statistics and Probability 282
Countries citing papers authored by A.W.S. Ritchie
This map shows the geographic impact of A.W.S. Ritchie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.W.S. Ritchie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.W.S. Ritchie more than expected).
Fields of papers citing papers by A.W.S. Ritchie
This network shows the impact of papers produced by A.W.S. Ritchie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.W.S. Ritchie. The network helps show where A.W.S. Ritchie may publish in the future.
Co-authors
The 25 scholars most cited alongside A.W.S. Ritchie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial Hit paper breakdown → | 2015 | 1540 |
| 2 | Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy Hit paper breakdown → | 2017 | 1350 |
| 3 | Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial Hit paper breakdown → | 2018 | 910 |
| 4 | Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019) Hit paper breakdown → | 2014 | 327 |
| 5 | Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial Hit paper breakdown → | 2019 | 313 |
| 6 | 2018 | 196 | |
| 7 | 1983 | 176 | |
| 8 | 2019 | 167 | |
| 9 | 2015 | 145 | |
| 10 | The natural history of renal carcinoma. | 1983 | 139 |
| 11 | 2012 | 135 | |
| 12 | 1985 | 119 | |
| 13 | 1984 | 99 | |
| 14 | 2012 | 96 | |
| 15 | 2020 | 95 | |
| 16 | 1988 | 69 | |
| 17 | The distribution and possible significance of cells identified in human lymphoid tissue by the monoclonal antibody HNK-1. | 1983 | 67 |
| 18 | 2022 | 64 | |
| 19 | 1987 | 60 | |
| 20 | 2017 | 53 |
About A.W.S. Ritchie
A.W.S. Ritchie is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Surgery, Oncology and Immunology, having authored 94 papers that have together received 7.1k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (29 papers), Prostate Cancer Diagnosis and Treatment (18 papers), Renal cell carcinoma treatment (15 papers), Bladder and Urothelial Cancer Treatments (8 papers), Cancer Genomics and Diagnostics (7 papers), Kidney Stones and Urolithiasis Treatments (7 papers), Immune Cell Function and Interaction (6 papers) and Renal and related cancers (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.9k citations), Cancer Research (1.0k citations), Radiology, Nuclear Medicine and Imaging (925 citations), Oncology (912 citations) and Statistics and Probability (282 citations). A.W.S. Ritchie has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include K. James, G. D. CHISHOLM, G. D. Chisholm, H. Spedding Micklem, Nicholas David James, Matthew Robert Sydes, Noel William Clarke, Mahesh Parmar, David Paul Dearnaley and Malcolm David Mason. Their work appears in journals such as Annals of Oncology, The Journal of Urology, European Urology, British Journal of Urology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.